Junxiong Chen

911 total citations
28 papers, 719 citations indexed

About

Junxiong Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junxiong Chen has authored 28 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Junxiong Chen's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (4 papers). Junxiong Chen is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (4 papers). Junxiong Chen collaborates with scholars based in China, Japan and United States. Junxiong Chen's co-authors include Huanliang Liu, Xiangling Yang, Lan Huang, Chuangyu Wen, Aikichi Iwamoto, Weiqian Li, Mengmeng Lin, Ruixian Liu, Lu He and Chenliang Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and British Journal of Cancer.

In The Last Decade

Junxiong Chen

26 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junxiong Chen China 15 463 271 111 93 77 28 719
Chuangyu Wen China 18 506 1.1× 279 1.0× 113 1.0× 55 0.6× 63 0.8× 34 752
Jia‐Sin Yang Taiwan 17 557 1.2× 241 0.9× 165 1.5× 59 0.6× 63 0.8× 30 855
Ji-Hak Jeong South Korea 15 369 0.8× 182 0.7× 151 1.4× 45 0.5× 138 1.8× 24 684
Baobing Zhao China 18 485 1.0× 105 0.4× 85 0.8× 96 1.0× 124 1.6× 55 880
Brian D. Koh United States 12 702 1.5× 291 1.1× 218 2.0× 63 0.7× 87 1.1× 17 942
Chandan Kanta Das India 13 486 1.0× 236 0.9× 157 1.4× 32 0.3× 54 0.7× 20 816
Anuradha Kirtonia India 10 563 1.2× 284 1.0× 173 1.6× 36 0.4× 71 0.9× 12 904

Countries citing papers authored by Junxiong Chen

Since Specialization
Citations

This map shows the geographic impact of Junxiong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junxiong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junxiong Chen more than expected).

Fields of papers citing papers by Junxiong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junxiong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junxiong Chen. The network helps show where Junxiong Chen may publish in the future.

Co-authorship network of co-authors of Junxiong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Junxiong Chen. A scholar is included among the top collaborators of Junxiong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junxiong Chen. Junxiong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jingdan, Haiyan Dong, Limei Hu, et al.. (2025). Targeting gut microbiota and arginase boosts MEK inhibitors’ enhancement of antitumour immunity via MHC-I upregulation in colorectal cancer. British Journal of Cancer. 133(6). 809–822.
2.
Liu, Jun, Xiaochuan Chen, Jiaqi Liu, et al.. (2024). 4′-Demethylpodophyllotoxin functions as a mechanism-driven therapy by targeting the PI3K-AKT pathway in Colorectal cancer. Translational Oncology. 51. 102199–102199.
3.
Ye, Linsen, Junxiong Chen, Jingdan Zhang, et al.. (2024). Tumor derived exosomal ENTPD2 impair CD8+ T cell function in colon cancer through ATP-adenosine metabolism reprogramming. Cell Communication and Signaling. 22(1). 274–274. 7 indexed citations
4.
Zhang, Jingdan, Junxiong Chen, Tian Yu, et al.. (2024). Bazedoxifene attenuates dextran sodium sulfate-induced colitis in mice through gut microbiota modulation and inhibition of STAT3 and NF-κB pathways. European Journal of Pharmacology. 974. 176611–176611. 1 indexed citations
5.
Feng, Yanchun, Yingming Jiang, Jun O. Liu, et al.. (2023). Targeting RPA promotes autophagic flux and the antitumor response to radiation in nasopharyngeal carcinoma. Journal of Translational Medicine. 21(1). 738–738. 5 indexed citations
6.
Tian, Yu, Junxiong Chen, Yixi Su, et al.. (2023). Knockdown LIMP2 inhibits colorectal cancer cells migration, invasion, and metastasis. Experimental Cell Research. 431(1). 113757–113757. 1 indexed citations
7.
Liu, Ruixian, Chuangyu Wen, Wei‐Biao Ye, et al.. (2023). Altered B cell immunoglobulin signature exhibits potential diagnostic values in human colorectal cancer. iScience. 26(3). 106140–106140. 6 indexed citations
8.
Wang, Zihan, Jiancong Hu, Junxiong Chen, et al.. (2022). ICAT promotes colorectal cancer metastasis via binding to JUP and activating the NF‐κB signaling pathway. Journal of Clinical Laboratory Analysis. 36(10). e24678–e24678. 8 indexed citations
9.
Huang, Lan, Yu Zhang, Xiaoting Chen, et al.. (2022). METTL3 promotes colorectal cancer metastasis by promoting the maturation of pri-microRNA-196b. Journal of Cancer Research and Clinical Oncology. 149(8). 5095–5108. 14 indexed citations
10.
Wang, Yang, Jing Zhang, Liye Zhong, et al.. (2021). Hsa‐miR‐335 enhances cell migration and invasion in lung adenocarcinoma through targeting Copine‐1. SHILAP Revista de lepidopterología. 2(4). 810–820. 9 indexed citations
11.
Zhang, Jingdan, Xiangling Yang, Lili Wei, et al.. (2020). Improved diagnostic value by combining plasma PON1 level with tumor biomarkers in Colorectal Cancer patients. Journal of Cancer. 11(22). 6491–6496. 7 indexed citations
12.
Chen, Junxiong, Xiangling Yang, Ruixian Liu, et al.. (2020). Circular RNA GLIS2 promotes colorectal cancer cell motility via activation of the NF-κB pathway. Cell Death and Disease. 11(9). 788–788. 41 indexed citations
13.
Wang, Huihui, Chuangyu Wen, Siyu Chen, et al.. (2020). Toosendanin-induced apoptosis in colorectal cancer cells is associated with the κ-opioid receptor/β-catenin signaling axis. Biochemical Pharmacology. 177. 114014–114014. 26 indexed citations
14.
Yang, Xiangling, Junxiong Chen, Lan Huang, et al.. (2019). MiR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10. Bioscience Reports. 39(12). 32 indexed citations
15.
Wen, Chuangyu, Huihui Wang, Xiaobin Wu, et al.. (2019). ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin. Cell Death and Disease. 10(11). 809–809. 90 indexed citations
16.
Huang, Lan, Chuangyu Wen, Xiangling Yang, et al.. (2018). PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d. Cell Death and Disease. 9(3). 271–271. 45 indexed citations
17.
Chen, Junxiong, Lu He, Chuangyu Wen, et al.. (2018). Reduced-gliotoxin induces ROS-mediated anoikis in human colorectal cancer cells. International Journal of Oncology. 52(3). 1023–1032. 25 indexed citations
18.
Wen, Chuangyu, Junxiong Chen, Di Zhang, et al.. (2016). Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells. Cancer Letters. 383(2). 295–308. 33 indexed citations
19.
Huang, Lan, Xiaoyan Wang, Chuangyu Wen, et al.. (2015). Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-α induced epithelial-to-mesenchymal transition in colorectal cancer. Scientific Reports. 5(1). 13350–13350. 76 indexed citations
20.
Wen, Chuangyu, Lan Huang, Junxiong Chen, et al.. (2015). Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells. International Journal of Oncology. 47(5). 1663–1671. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026